Quantum Genomics strengthens its management team by appointing Marc Karako, Chief Financial Officer, and Jean-Philippe Milon, Chief Operating Officer - 2014-05-14

Quantum Genomics, an innovative biopharmaceutical company developing new therapies for cardiovascular diseases (Alternext – FR0011648971 – ALQGC), announces the appointment of Marc Karako and Jean-Philippe Milon, respectively CFO and COO. They will strengthen the management team of Quantum Genomics, supporting Lionel Ségard, Chairman and CEO, and Fabrice Balavoine, Vice President Research & Development.

Download the pdf